Vaccine News – Israeli News Live – Special Report: The Dangers of Vaccines -dr. Sherri Tenpenny

Israeli News Live – Special Report: The Dangers of Vaccines -dr. Sherri Tenpenny
Jana Bennun took time out with Dr. Sherri Tenpenny to discuss the DANGERS of Vaccines.
Dr. Sherri is a Medical Doctor, Author, Lecturer and an Activist against the vaccine agenda.
Links:
http://vaxxter.com
http://wellnesssoldier.com
https://vaccineresearchlibrary.com
http://tenpennyimc.com
https://www.facebook.com/vaccineinfo
https://www.facebook.com/vaxxterinfo
https://www.facebook.com/wellnesssoldier
https://www.facebook.com/VaccineResearchLibrary
https://www.facebook.com/tenpennyimc/
https://www.facebook.com/groups/VaccineChoices

Dancer, 18, is paralysed from waist down after ‘having cervical cancer vaccine’
Chloe Brookes-Holder, 18, believes the vaccine led to her illness despite the World Health Organisation saying there is no credible evidence of a link between HPV and chronic illnesses
ByKara O’NeillShanti Das 11:51, 3 MAR 2017
A teenage dancer has been paralysed from the waist down and may never walk again after suffering from devastating chronic illnesses which she claims were caused by the HPV cervical cancer vaccine.
Chloe Brookes-Holder, 18, and her family believe that the jabs have left her with a range of chronic illnesses including weakened muscles, fatigue and bone pain.

Six doctors who have administered vaccines in their practiced are all asked the same question. When you were in medical school, how much education regarding vaccines was provided before you were permitted to administer them?
Interviews, camera and editing by Joshua Coleman.

#VaxxedDoctors #Vaxxed #Truth #Science #RFKcommission #MedicalProfessionals

 

First Look at The Truth About Vaccines – Interview with Sayer Ji and Dr. Judy Mikovits about retroviruses and something horrific called “reverse transcriptase” in the MMR vaccine which can actually insert animal diseases into our own human DNA.
http://bit.ly/ttavtrailerttacfb

HOW MUCH DO YOU REALLY KNOW ABOUT THE FLU VACCINE?
The flu shot is now recommended for every American every year. This push has made it the most widely-used vaccine in our country. But it is also the least effective and has the most reported side effects of all vaccines. Watch this video before you decide if the flu shot is “safe and effective” enough for you.
You can also watch on our website or YouTube channel.

Study – Chickenpox vaccination increases incidence of shingles in younger adults
August 12, 2015 at 3:22 AM
Vaccinating one-year-olds against chickenpox could temporarily nearly double the incidence of shingles in the wider population, but in younger adults than previously thought.
The effect occurs because vaccination reduces the likelihood of adults who experienced chickenpox as a child being re-exposed to the virus. Re-exposure boosts immunity to shingles, caused by the same virus, Varicella-zoster virus.
In a study to be published in the journal eLife, scientists from the Universities of Antwerp and Hasselt (Belgium) have predicted that the temporary effect of a rise in shingles cases dominates in 31 to 40-year-olds. This is younger than previously predicted and this age group is less at risk of developing the most serious shingles symptoms. Many countries have avoided introducing universal chickenpox vaccination in children because it was previously predicted that the reduction in chickenpox related disease would be outbalanced by the temporarily increase in shingles-related disease.
A new model developed by the scientists also confounds previous findings on the length of time re-exposure chickenpox boosts immunity to shingles. The effect was thought to last for up to 20 years, but results of the current modeling study show it only lasts for two. The new model is the first based on real immunological and virological data from individuals.
“We were surprised to find that re-exposure to chickenpox is beneficial for so few years and also that the most pronounced effect of vaccination on increasing cases of shingles is in younger adults,” says lead author Dr Benson Ogunjimi.
“Our findings should allay some fears about implementing childhood chickenpox vaccination,” he says.

Is YOUR Baby Getting Too Much Aluminum?
Did you know vaccines contain 50 times the FDA safety limit of aluminum in each round of infant shots? Watch this video to see if YOUR baby is getting too much aluminum.
Resources:
FDA Code of Federal Regulations Title 21, subchapter C, part 201, subpart G, section 201.323
FDA: Aluminum in Large and Small Volume Parenterals Used in Total Parenteral Nutrition
Aluminum toxicity in infants and children, Committee on Nutrition, American Academy of Pediatrics, Pediatrics 1996; 97:413-16
ASPEN statement on aluminum in parenteral nutrition solutions, Charney P., Aluminum Task Force, Nutrition in Clinical Practice 2004; 19:416-17
Aluminum neurotoxicity in preterm infants receiving intravenous feeding solutions, Bishop NJ, et al., New England Journal of Medicine 1997; 336(22):1557-61
FDA: Vaccine Package Inserts for DTaP, Hepatitis B, Hepatitis A, Pneumococcal, Hib (PedVaxHib brand), HPV, Pentacel, and Pediarix
Children’s Hospital of Philedelphia Vaccine Education Center website: Vaccine Ingredients – Aluminum

Studies on adverse reactions from 1926 to 2009

The Connection Between Autism and Brain Inflammation
Autism spectrum disorders (ASDs) now affect as many as 1 in 45 children — and the numbers are rising. Considered a neurodevelopment disorder, autism is characterized by varying degrees of dysfunctional communication and social interactions, repetitive and stereotypic behaviors, as well as learning and sensory deficits. Researchers are scrambling to pinpoint the reason for this disturbing trend, but the disorder has proven to be incredibly complex and treatment options are limited.
A promising study published during the summer of 2016 in Translational Psychiatry may shed some much needed light on the root cause of the disorder — and how to address it.
Dr. Theoharides and his colleagues — in collaboration with Tufts University School of Medicine, Sackler School of Graduate Biomedical Sciences, and the Department of Child Psychiatry at Harvard Medical School — believe they may have uncovered a significant cause of the core symptoms of ASD. Dr. Theoharides is considered an expert in his field and is within the top five percent of most quoted authors in scientific papers.
Study – Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders

Autism Rates in California Schools Jumped As Much as 17% Among Kindergartners Since Mandatory Vaccine Bill Was Signed
by Yelena Sukhoterina | August 24, 2016
Autism rates in the US have been rising since the 1980s. In 1985 autism prevalence was 1 in 2,500, ten years later it jumped to 1 in 500, and today it is an astonishing 1 in 68 children.
More and more researchers and doctors are raising red flags as they see more evidence that this epidemic is related not only to environmental, food, and water toxins, but specifically to those in vaccinations. In 1995, the immunization schedule for children had 19 vaccinations before the age of 16. In 2001, that number is now 28 before the age of 18.
Following the 2016 schedule, a child can receive up to 72 vaccinations if they have all the doses of the vaccines, all the boosters, and a double-dose of the annual flu shot done.
While the state of California has long been in favor of natural medicine and freedom to choose your own method of healing, all that changed in June 2015 when Governor Jerry Brown signed the controversial SB277 bill eliminating personal and religious exemptions for vaccines.
Could the increased rates be contributing even partly to a stunningly quick rise in autism rates?

Robert De Niro, Robert F. Kennedy Jr. offer $100K to anyone who can provide proof vaccines are safe
By Katie Scott    National Online Journalist, Smart Living & Entertainment  Global News
Robert De Niro joined Robert F. Kennedy Jr. in Washington, D.C. on Feb. 15 to hold a press conference about vaccine safety.
The pair are looking for proof that vaccines are safe and teamed up to offer $100,000 to anyone who can provide such information.
The actor participated in the panel, which showcased discredited claims surrounding vaccination, including the notion that they cause autism and that high levels of mercury in immunizations can make kids sick.
“On one hand, the government is telling pregnant women which mercury-laced fish to avoid so that they don’t harm their fetuses, and on the other, the CDC supports injecting mercury-containing vaccines into pregnant women, infants and children,” Kennedy said at the joint press conference Wednesday.

Dells passionate message to Doctors from episode 4 the Truth About Vaccines…
3 min viewing time.
Lets put our Doctors to the test and see if they know the ingredients in the vaccines they recommend.
Ask the question- are you fully vaccinated as per the recommended childhood schedule.
Do they Vaccinate their children?
Is there a STOP button on a vaccine?
Doctors need to be fully informed…

MEASLES VACCINATION RESULTS IN HORRIFIC RASHES AND ILLNESS ON CHILDREN
HUNDREDS of children between the ages of 1 to 14 have been admitted in hospitals across Lesotho after a nationwide vaccination for measles and rubella (MR) resulted in horrific skin rashes, fever and muscle pain.
The vaccinations were carried out in February under the authority of the Lesotho ministry of health headed by Dr Molotsi Monyamane, in association with World Health Organization and UNICEF.
At a press conference on Thursday last week Dr Monyamane didn’t fully acknowledge that the MR jabs which were administered in homes, schools and clinics were the main cause of ill effects on hundreds of children and the death of at least one child.
Instead the minister downplayed the effects of the vaccination by saying the children who have come out with rashes and other illnesses might be undernourished, hence their reaction to the vaccine.
‘We don’t have proof that the pictures posted on social media are truly for children who got such side effects from the vaccination,” Dr Monyamane said.
He added: “Do not bring us pictures, bring those children here we have a specialist here. Parents should bring documented evidence from health professionals that prove that the children`s illness is a result of the vaccine. Take your children to the health facilities; I do not know what is ailing the children. Let’s all investigate what is causing this outbreak. We can’t attribute every illness in the country to the vaccine.”
Dr Monyamane’s dismissive attitude has offended scores of parents some of who are considering legal action against him and the ministry of health.
One mother who didn’t want to be identified told Team Buntu Africa that her once perfectly healthy five-year old son has been sick since being vaccinated with MR.

Dirty Vaccines: Every Human Vaccine Tested Was Contaminated With Metals and Debris in New Study
Posted on: Thursday, February 2nd 2017 at 1:15 am
Written By: Celeste McGovern
Study – New Quality-Control Investigations on Vaccines Micro and Nanocontamination
Researchers examining 44 samples of 30 different vaccines found dangerous contaminants, including red blood cells in one vaccine and metal toxicants in every single sample tested – except in one animal vaccine.
Using extremely sensitive new technologies not used in vaccine manufacturing, Italian scientists reported they were “baffled” by their discoveries which included single particles and aggregates of organic debris including red cells of human or possibly animal origin and metals including lead, tungsten, gold, and chromium, that have been linked to autoimmune disease and leukemia.
In the study, published this week in the International Journal of Vaccines and Vaccination, the researchers led by Antoinetta Gatti, of the National Council of Research of Italy and the Scientific Director of Nanodiagnostics, say their results “show the presence of micro- and nano-sized particulate matter composed of inorganic elements in vaccine samples” not declared in the products’ ingredients lists.
Lead particles were found in the cervical cancer vaccines, Gardasil and Cevarix, for example, and in the seasonal flu vaccine Aggripal manufactured by Novartis as well as in the Meningetec vaccine meant to protect against meningitis C.
Samples of an infant vaccine called Infarix Hexa (against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and haemophilus influenzae type B) manufactured by GlaxoSmithKline was found to contain stainless steel, tungsten and a gold-zinc aggregate.
Other metal contaminants included platinum, silver, bismuth, iron, and chromium. Chromium (alone or in alloy with iron and nickel) was identified in 25 of the human vaccines from Italy and France that were tested.
GSK’s Fluarix vaccine for children three years and older contained 11 metals and aggregates of metals. Similar aggregates to those identified in the vaccines have been shown to be prevalent in cases of leukemia, the researchers noted.

Whooping cough resurgence due to vaccinated people not knowing they’re infectious?
Date:
June 24, 2015
Source:
Santa Fe Institute
Summary:
The dramatic resurgence of whooping cough is due, in large part, to vaccinated people who are infectious but who do not display the symptoms, suggests a new study.
Whooping cough has made an astonishing comeback, with 2012 seeing nearly 50,000 infections in the U.S. (the most since 1955), and a death rate in infants three times that of the rest of the population. The dramatic resurgence has puzzled public health officials, who have pointed to the waning effectiveness of the current vaccine and growing anti-vaccine sentiment as the most likely culprits.
But that might not be the whole story, suggests a new study published in BMC Medicine by Santa Fe Institute Omidyar Fellows Ben Althouse and Sam Scarpino. Their research points to a different, but related, source of the outbreak — vaccinated people who are infectious but who do not display the symptoms of whooping cough, suggesting that the number of people transmitting without symptoms may be many times greater than those transmitting with symptoms.
In the 1950s, highly successful vaccines based on inactivated pertussis cells (the bacteria that causes whooping cough) drove infection rates in the U.S. below one case per 100,000 people. But adverse side effects of those vaccines led to the development and introduction in the 1990s of acellular pertussis vaccines, which use just a handful of the bacteria’s proteins and bypass most of the side effects. (Currently given to children as part of the Tdap vaccine.)
The problem is, the newer vaccines might not block transmission. A January 2014 study in PNAS by another research team demonstrated that giving baboons acellular pertussis vaccines prevented them from developing symptoms of whooping cough but failed to stop transmission.
Building on that result, Althouse and Scarpino used whopping cough case counts from the CDC, genomic data on the pertussis bacteria, and a detailed epidemiological model of whooping cough transmission to conclude that acellular vaccines may well have contributed to — even exacerbated — the recent pertussis outbreak by allowing infected individuals without symptoms to unknowingly spread pertussis multiple times in their lifetimes.
‘There could be millions of people out there with just a minor cough or no cough spreading this potentially fatal disease without knowing it,’ said Althouse. ‘The public health community should act now to better assess the true burden of pertussis infection.’

 

 

Flu Vaccine is the most Dangerous Vaccine in the U. S. based on Settled Cases for Injuries

Flu Vaccine is the most Dangerous Vaccine in the U. S. based on Settled Cases for Injuries
Attorney Howard Gold of Gold Law Firm, who settled a case for GBS due to a flu vaccine in 2011, remarked:
Petitioners have three (3) years from the onset of the injury (or two years from date of death) to file a claim. Gold states that the “Program is not used as much as it could be because the American public is just not aware of it. I receive at least 5 calls a month from individuals who cannot obtain compensation because the deadline has passed. They just found out about it too late. We all need to do a better job in getting the word out to the public that the Program exists.” (Source.)
In November 2013, a healthy 19-year old young man died from a routine exam that included the flu vaccine. Chandler Webb received the flu shot on October 15th, and then died on November 19th, 28 days later. Since the flu shot is considered safe in the medical field, doctors waited too long to suspect that the flu shot was causing Chandler’s rapidly deteriorating medical condition, according to his mother. She believes that if they had investigated the adverse reaction to the flu shot immediately, he might still be alive today.

Just a quick cursory view of cases that are being compensated by this vaccine court shows that the most cases, by far, are cases for GBS and the flu vaccine.
The U.S Court of Federal Claims provides a referral list of attorneys that specialize in representing clients wanting to file claims for vaccine damages. The list is here, and contains 123 attorneys.
One of the law firms representing clients in the Vaccine Court is Maglio, Christopher, & Toale. This law firm has actually listed cases they have settled in the past couple of years here.
From what appears to be some point in 2010 through 2013, they have settled 132 cases

Preliminary Results: Surveillance for Guillain-Barré Syndrome After Receipt of Influenza A (H1N1) 2009 Monovalent Vaccine — United States, 2009–2010
GBS incidence was calculated and compared for the vaccinated and unvaccinated populations, which were estimated by age group, using data from CDC’s Behavioral Risk Factor Surveillance System (BRFSS) and National 2009 H1N1 Flu Survey (NHFS) telephone survey data for the counties in the EIP catchment areas, using methods published previously (4). The total person-time of follow-up was calculated by multiplying the population under surveillance by the number of days since the start of surveillance, October 1, 2009. Person-time at risk for GBS in the vaccinated population was calculated by multiplying the number of vaccinees by 42 days (or the number of days from vaccination to the end of the surveillance period if <42 days) (1). Children aged 6 months–9 years who received a second dose of 2009 H1N1 vaccine were presumed to have received it 28 days after the first dose, as recommended by the Advisory Committee on Immunization Practices,¶ giving them an additional 28 days of person-time at risk. To calculate the corresponding person-time in the unvaccinated population, the person time at risk for GBS was summed among the vaccinated population and then subtracted from the total person-time of follow-up under surveillance.
Incidence among the vaccinated population was calculated by dividing the number of GBS cases vaccinated within the risk window by the total amount of person-time at risk following vaccination. Incidence among the unvaccinated population was calculated by dividing the number of GBS cases unexposed to vaccine or exposed to vaccine outside the risk window by the total amount of person-time unexposed to 2009 H1N1 vaccine. Bootstrapping methods were used to estimate 95% confidence intervals (CIs) for the rate ratios that incorporated the variance of vaccine coverage estimates (5). A Poisson distribution was assumed for the occurrence of cases and a normal distribution for the vaccine coverage estimates; the Mantel-Haenszel method was used for age-adjusted CIs. A temporal scan statistic was used to assess for any significant clustering in the interval between vaccination and illness onset in vaccinated cases (6).
During October 1, 2009–May 10, 2010, a total of 529 reports of potential GBS were identified by EIP, of which 326 met the GBS case criteria. Of the 326 persons with GBS, 27 had documentation of 2009 H1N1 vaccination in the 42 days preceding illness onset, 274 did not receive vaccine, and the vaccine status of 25 was either unknown (six) or pending ascertainment (19) (Table 1). Sixteen of the 27 (59%) with documentation of 2009 H1N1 vaccination also reported antecedent illness symptoms in the 42 days before GBS onset; 78% of unvaccinated persons with GBS (215 of 274) reported antecedent symptoms (p=0.04). No clustering among vaccinated persons was observed in the period between vaccination and illness onset (p=0.54). Among the 27 GBS patients with 2009 H1N1 vaccination, four required ventilator support, and one remained hospitalized 30 days after GBS onset; among the 274 GBS patients who did not receive 2009 H1N1 vaccination, 37 (14%) required ventilator support, and 34 (12%) remained hospitalized after 30 days. Eight (2%) of the 326 GBS patients died (from any cause); none of the eight had received the 2009 H1N1 vaccine within 42 days of illness onset.
Among patients hospitalized through March 31, 2010, comparison of the incidence of GBS among those who received 2009 H1N1 vaccine and those who did not receive the vaccine revealed an age-adjusted rate ratio of 1.77 (CI = 1.12–2.56) (Table 2). If this preliminary rate ratio is confirmed in end-of-surveillance analyses, the attributable rate of GBS would be 0.71 per 100,000 person-years, corresponding to an attributable risk of 0.8 excess cases of GBS per 1 million vaccinations.**

Risk of Guillain-Barré Syndrome Following H1N1 Influenza Vaccination in Quebec
RESULTS
During the active surveillance period, 61 possible GBS cases were reported to public health authorities. Seventy-seven possible GBS cases were retrospectively identified in the MEDECHO hospital admission database. Thirty-seven cases were found in both sources, for a total of 101 cases. For all 101, medical charts were retrieved and analyzed. Eighteen possible cases were excluded: 12 cases with a final diagnosis other than GBS, 2 recurrent GBS cases, 2 cases with disease onset before October 13, 2009, and 2 other cases with onset after March 31, 2010. Thus, 83 cases were included in the analysis. The overall GBS incidence rate in the study population, representing 3 623 046 person-years of observation, was 2.3 per 100 000.
Of the 83 confirmed GBS cases included in the analysis, 42 had been immunized before disease onset (1-121 days after immunization) and all had received the ASO3 adjuvant H1N1 vaccine. For 25 cases, disease onset was 8 or fewer weeks after the vaccine was administered and they were considered exposed, whereas the 17 other cases were immunized more than 8 weeks before disease onset and were considered unexposed. Thus, for the cohort analysis, 25 GBS cases were considered exposed and 58 cases were considered unexposed.
The characteristics of GBS cases according to exposure status are shown in Table 1. Forty-nine cases were classified in the Brighton level 1 category, 22 cases in level 2, and 12 cases in level 4. The distribution of cases according to diagnostic category was similar in exposed and unexposed cases. The percentage of male patients was 69%. The median age was 49 years (range, 1-89 years). The percentage of elderly patients was higher in the exposed group than the unexposed group. The majority of patients (96%) were hospitalized; 25% developed severe paralysis of the lower limbs and were unable to walk at some point; and 17% developed respiratory distress syndrome and required intubation and/or assisted ventilation. Four patients died, all of whom were older than 60 years. Conditions occurring within 1 month before GBS onset as reported in medical records included a respiratory tract infection or influenzalike illness in 36% of cases, gastroenteritis in 18%, and trauma in 4%. A history of infection during the month prior to hospitalization was less frequent in exposed than in unexposed patients. The median interval between disease onset and hospitalization was 5 days (range, 1-34 days).
Of the 83 confirmed GBS cases identified during the 6-month study period, 56 (67% of total) occurred during a 12-week period from October 18, 2009 (2009 Centers for Disease Control and Prevention [CDC] week 42) to January 9, 2010 (2010 CDC week 1). The cluster was mostly explained by cases occurring in persons who were recently (≤8 weeks) immunized (22/56). Details on the distribution of cases are provided in eFigure 1.

Sudden Infant Death Syndrome Rates (SIDS) Linked To Increased Vaccination Dosage

Sudden Infant Death Syndrome Rates (SIDS) Linked To Increased Vaccination Dosage

Sudden Infant Death Syndrome (SIDS)
The Thinktwice Global Vaccine Institute receives numerous emails every day. On this webpage you will find a small sample of these unsolicited personal letters linking vaccines to sudden infant death syndrome (SIDS). This webpage also includes an excerpt on SIDS from the U.S. Congressional records. We also recommend the Free SIDS Report on vaccines and Sudden Death. It includes numerous studies and other documentaion confirming a link between vaccines and infant fatalities. Be sure to read the most recent reader emails as well, which include numerous vaccine questions, comments, concerns, and unsolicited personal stories.

Special Reports

Study here:
Comparison of VAERS fetal-loss reports during three consecutive influenza seasons: Was there a synergistic fetal toxicity associated with the two-vaccine 2009/2010 season?
Abstract
The aim of this study was to compare the number of inactivated-influenza vaccine–related spontaneous abortion and stillbirth (SB) reports in the Vaccine Adverse Event Reporting System (VAERS) database during three consecutive flu seasons beginning 2008/2009 and assess the relative fetal death reports associated with the two-vaccine 2009/2010 season. The VAERS database was searched for reports of fetal demise following administration of the influenza vaccine/vaccines to pregnant women. Utilization of an independent surveillance survey and VAERS, two-source capture–recapture analysis estimated the reporting completeness in the 2009/2010 flu season. Capture–recapture demonstrated that the VAERS database captured about 13.2% of the total 1321 (95% confidence interval (CI): 815–2795) estimated reports, yielding an ascertainment-corrected rate of 590 fetal-loss reports per million pregnant women vaccinated (or 1 per 1695). The unadjusted fetal-loss report rates for the three consecutive influenza seasons beginning 2008/2009 were 6.8 (95% CI: 0.1–13.1), 77.8 (95% CI: 66.3–89.4), and 12.6 (95% CI: 7.2–18.0) cases per million pregnant women vaccinated, respectively. The observed reporting bias was too low to explain the magnitude increase in fetal-demise reporting rates in the VAERS database relative to the reported annual trends. Thus, a synergistic fetal toxicity likely resulted from the administration of both the pandemic (A-H1N1) and seasonal influenza vaccines during the 2009/2010 season

Judges demand answers after children die in controversial cancer vaccine trial in India

Judges demand answers after children die in controversial cancer vaccine trial in India
Tribal girls were given shots of cervical cancer vaccines during trial
Children given Merck’s Gardasil and Cervarix vaccines
Petitioners also asked judges to investigate trials of new drug Gardasil 9
Drug has allegedly caused side-effects in children as young as nine
Investigation claims children were used as unwitting human guinea pigs
Supreme Court has given the government one month to provide answers

In 2009, tribal children from the Khammam district in Andhra Pradesh were administered with a Human Papilloma Virus (HPV) vaccine meant for cervical cancer. Around 16,000 girls between the age of 9-15 years were given three shots of vaccine, (manufactured by Merck) by the state health department. The girls were told that they were being given “well-being” shots. The incident started getting attention when some months later, several girls’ health deteriorated and the following year, five of them died. Two such similar cases of deaths were reported from Vadodara, Gujarat, where 14,000 tribal children were also vaccinated with the HPV vaccine Cervarix, made by Glaxo SmithKline.
Around the same time when these incidents were reported, young girls were hospitalised in northern Colombia with similar symptoms. Coincidentally, these girls had been given doses of vaccine too.
Skeletons started tumbling out when an NGO visited Andhra Pradesh. Health activists from the NGO Sama visited Khammam in March 2010 and found out that more than 100 girls were having epileptic seizures, stomach aches, headaches and mood swings. The girls also complained about early menstruation, heavy bleeding and menstrual cramps. Sama raised the issue that these students were made guinea pigs on the pretext of providing healthcare. The illiterate parents were kept in the dark about the real vaccine, and most of them gave their consent in the form of thumb prints.

What: A Phase V human papilloma virus (HPV) Phase V vaccine trial in Andhra Pradesh & Gujarat, India
PATH carried out a large  HPV Phase V vaccine trial in India. Phase V means using approved, not test, vaccines. Certain forms of HPV are associated with cervical cancer. The vaccines in question, Gardasil from Merck and Cervarix from GlaxoSmithKline, were granted marketing approval in India in 2008 while the PATH-sponsored trial began in 2009 as a joint project with the ICMR, using donated vaccines.
The purpose of the trial was to generate data to support the inclusion of the HPV vaccine in India’s Universal Immunization Programme (UIP).
Specifically recruiting from low-income rural, largely tribal, households, the trial was conducted on girls aged 10 to 14 using Gardasil in Khammam district of Andhra Pradesh (AP) state (n=13000), and using Cervarix in Vadodara in Gujarat state (n=10000).
The Problems
Public recognition of problems with this trial started with the reported death of 7 girls. This led to immediate suspension of the trial in 2010 even though it was supposed to run until 2011. Investigations showed these deaths weren’t directly connected to the vaccines (see table from the initial official investigation report, 1).
However, investigations triggered by these deaths instead uncovered serious violations of the process of informed consent (see official investigation reports below from 1, see also 2). Aged 10 to 15, girls in this trial were obviously below the age of  consent meaning their participation in the trial required the consent of  parents/guardians. In the course of Government of India (GOI)  investigations, the trial investigators ‘were asked to submit 100 consent forms, chosen randomly, for both AP and Gujarat for independent verification’ (1). These consent forms turned out to have several problems (see reports below from 1).

Young Tribal Girls Tested With HPV Vaccines

Young Tribal Girls Tested With HPV Vaccines
The Economic Times India published their report August 2014. They stated that in 2009, tests had been carried out on 16,000 tribal school children in Andhra Pradesh, India, using the human papiloma virus (HPV) vaccine, Gardasil.
According to the report written by KP Narayana Kumar, within a month of receiving the vaccine, many of the children fell ill and by 2010, five of them had died. A further two children were reported to have died in Vadodara, Gujarat, where an estimated 14,000 tribal children were vaccinated with another brand of the HPV vaccine, Cervarix, manufactured by GlaxoSmitheKline (GSK).
Shockingly, the report stated that many of the consent forms used to vaccinate the girls were signed “illegally,” either by the wardens from the hostels where many of the girls resided, or using thumbprints from illiterate parents.

TORONTO – A strange vaccine-related phenomenon spotted at the start of the 2009 flu pandemic may well have been real, a new study suggests.

http://www.metronews.ca/life/health/2012/09/09/canadian-problem-maybe-not-study-finds.html

Canadian researchers noticed in the early weeks of the pandemic that people who got a flu shot for the 2008-2009 winter seemed to be more likely to get infected with the pandemic virus than people who hadn’t received a flu shot.
Five studies done in several provinces showed the same puzzling and unsettling results. But initially research outside of Canada did not, and the effect was dismissed as “the Canadian problem.”
News of the unexpected findings broke at a time when countries in North America and parts of Europe were getting ready to start vaccinating their populations against the pandemic virus.